文献速递血栓与止血

静脉血栓栓塞症治疗中出血风险的评估与管理

How I assess and manage the risk of bleeding in patients treated for venous thromboembolism.
PubMed 文献 · Blood · 2020-01-01

本文针对静脉血栓栓塞症(VTE)患者,在治疗启动、出院、3个月随访和长期随访各阶段,出血风险预测的目的和方法不同。现有证据支持筛查和管理可改变的大出血危险因素,并应用决策规则识别低出血风险患者以安全进行长期抗凝。未来需将预测工具纳入随机对照试验,并研究纵向评估的价值。

要点

  • VTE治疗全程需动态评估出血风险,各阶段预测目的不同。
  • 应筛查并干预可改变的大出血危险因素。
  • 决策规则有助于识别低出血风险、适合长期抗凝的患者。

核心结论

  • 现有证据支持在VTE治疗中筛查和管理可改变的大出血危险因素,并应用决策规则识别低出血风险患者。

主要发现

  • 出血风险预测在VTE治疗启动、出院、3个月随访和长期随访阶段的目的和方法不同。
  • 即使缺乏成熟的预测方案和基于预测方案决定治疗的结局研究,现有证据仍支持筛查可改变的大出血危险因素。
  • 应用决策规则可识别出血并发症低风险患者,这些患者长期抗凝治疗可能安全。

临床怎么用

  • 在VTE治疗各阶段动态评估出血风险,针对可改变危险因素进行管理。
  • 使用决策规则筛选低出血风险患者,考虑长期抗凝治疗的安全性。

局限性

  • 尚缺乏完全建立的出血风险预测方案和基于预测方案决定治疗的结局研究。
  • 预测工具尚未在精心设计的随机对照试验中验证以确定高危复发VTE患者的最佳治疗时长。
  • 纵向评估出血风险相较于单独基线评估的获益尚未研究。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

For patients with venous thromboembolism (VTE), prediction of bleeding is relevant throughout the course of treatment, although the means and goal of this prediction differ between the subsequent stages of treatment: treatment initiation, hospital discharge, 3-month follow-up, and long-term follow-up. Even in the absence of fully established risk prediction schemes and outcome studies using a prediction scheme for treatment decisions, the present evidence supports screening for and targeting of modifiable risk factors for major bleeding, as well as the application of decision rules to identify patients at low risk of bleeding complications, in whom long-term anticoagulant treatment is likely safe. Moving forward, prediction tools need to be incorporated in well-designed randomized controlled trials aiming to establish optimal treatment duration in patients at high risk of recurrent VTE. Moreover, the benefit of their longitudinal assessment rather than application as stand-alone baseline assessments should be studied, because changes in bleeding risk over time likely constitute the best predictor of major bleeding. We provide the state-of-the-art of assessing and managing bleeding risk in patients with acute VTE and highlight a practical approach for daily practice illustrated by 2 case scenarios.

来源:Blood,查看原文。版权归原作者所有。

引用

  1. Klok FA, Huisman MV. How I assess and manage the risk of bleeding in patients treated for venous thromboembolism. Blood. 2020. PMID: 31951652. doi:10.1182/blood.2019001605

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。